Quick Answer
Lexeo Therapeutics, Inc. reported Total Assets of $268.69 million for fiscal year 2025.
Lexeo Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $268.69M | +82.9% |
| 2024 | $146.94M | +5.1% |
| 2023 | $139.81M | +44.0% |
| 2022 | $97.08M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $143.84M | -17.3% | -18.3% |
| June 30, 2025 | $176.07M | -8.3% | +40.1% |
| March 31, 2025 | $125.69M | -41.0% | -14.5% |
| December 31, 2024 | $146.94M | +5.1% | -15.5% |
| September 30, 2024 | $173.87M | +217.7% | -9.4% |
| June 30, 2024 | $192.01M | — | -9.9% |
| March 31, 2024 | $213.21M | — | +52.5% |
| December 31, 2023 | $139.81M | +44.0% | +155.5% |
- Lexeo Therapeutics, Inc. showed an increase of +82.9% in Total Assets compared to the prior fiscal year.
- Over the 2022–2025 period, Lexeo Therapeutics, Inc.’s total assets has grown by 176.8% (from $97.08 million to $268.69 million).
- The most recent figure is from Lexeo Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: